He's talking about a pharmacodynamic synthesis that includes an anti-CD38 antibody and a transparent He also mentioned a pharmacological synthesis containing an anti-CD38 antibody in SEC ID: 4 and VL ID: 5 (1200-5000 mg).A transparent rhuph20 (30000-45000 U),Thyroxine in concentrations ranging from 5 mm to 15 mm, 100 mm to 300 mm, PS-20 to 0.01% P / V to 0.04% P / V, 1 mg / ml to 2 mg / ml, pH 5.5, etc. These compositions are used to treat cancer.Se refiere a una composicion farmaceutica que comprende un anticuerpo anti-CD38 y una hialuronidasa. Tambien se refiere a una composicion farmaceutica que comprende un anticuerpo anti-CD38 con VH de SEC No. ID: 4 y VL de SEC No. ID: 5 (1200 a 5000 mg), una hialuronidasa rHuPH20 (30 000 a 45 000 U), histidina a una concentracion de 5Mm a 15 Mm, sorbitol a una concentracion de 100 Mm a 300 Mm, PS-20 a una concentracion de 0,01% p/v a 0,04% p/v, y metionina a una concentracion de 1mg/ml a 2mg/ml a un pH de 5.5, entre otros. Dichas composiciones son usadas para el tratamiento del cancer.
